Sci Adv 5(2):eaav416
The acquired resistance to ICB treatment might be due to cancer cell-intrinsic and -extrinsic changes, including the loss of MHC class I on cancer cells (175, 176), genetic mutations that diminish T-cell infiltration (177, 178), or host microbiota (179182)
common brand names include Ozempic and Wegovy (semaglutide), Mounjaro and Zepbound (tirzepatide, a dual GIP/GLP-1 drug), Trulicity (dulaglutide), Victoza and Saxenda (liraglutide), Byetta and Bydureon (exenatide), Adlyxin (lixisenatide), and Rybelsus (oral semaglutide), with generic options currently including liraglutide and exenatide in some markets
Both types of fiber are beneficial to your health for different reasons, but its soluble fiber in particular that will slow the rate of gastric emptying, similar to GLP-1s
In the CONQUER and EQUIP trials, which were the major studies leading to FDA approval: Patients on the highest dose lost an average of 10.9% to 12.4% of body weight over 56 weeks